Site predilection of extrapulmonary tuberculosis: study from a tertiary care centre

Authors

  • Rajani Mavila Deparment of Respiratorymedicine, Pariyaram Medical College, Kannur, Kerala
  • Manoj Kottarath Deparment of Respiratorymedicine, Pariyaram Medical College, Kannur, Kerala
  • Smitha Nair Deparment of Respiratorymedicine, Pariyaram Medical College, Kannur, Kerala
  • Milan Malik Thaha Deparment of Respiratorymedicine, Pariyaram Medical College, Kannur, Kerala

DOI:

https://doi.org/10.18203/2320-6012.ijrms20151197

Keywords:

Extra pulmonary tuberculosis, Lymph node, Gastro intestinal, Breast, Pericardium

Abstract

Background: Extrapulmonary tuberculosis (EPTB) still constitutes an important clinical problem. We aimed to evaluate the site prevalence of extrapulmonary tuberculosis.

Methods: We retrospectively evaluated 187 extrapulmonary tuberculosis patients diagnosed between 1st June 2013 and 31st May 2015 in a tertiary care hospital, Kanpur, Kerala, India.

Results: Among the extra pulmonary tuberculosis 112 (59.9%) were males. About 170 (90.9%) patients received CAT1 treatment and 17 (9%) patients received CAT2 treatment. Overall, the total number of different types of EPTB cases included Lymph node (n=55, 29.41%), GIT (n=45, 24.04%), Pleura (n=44, 23.53%), Skeletal (n =14, 7.49%), CNS (n=7, 3.74%) EPTB cases other site included mainly genitourinary (6), breast (6), skin (5), pericardium (3), Psoas (4) a vocal cord (1) and eye (1).

Conclusions: EPTB still constitutes an important clinical problem. In the current study, we assessed the site of predilection of EPTB patients. In this study, EPTB cases constituted 52.08% of all tuberculosis cases presented to our center in the study period. Lymph node tuberculosis is the most common type.

References

Fanning A. Tuberculosis. extrapulmonary disease. CMAJ. 1999;160:1597-603.

Iscman MD. Tuberculosis in relation to human immunodeficiency virus and acquired immunodeficiency syndrome. In: Iseman MD, editor. A clinician’s guide to tuberculosis. Philadelphia: Lippincott Williams and Wilkins. 2000:199-252.

Dutt AK, Stead WW. Epidemiology. In: Schlossberg D, editor.Tuberculois and nontuberculous mycobacterial infection. Philadelphia: W.B. Saunders Company; 1999:3-16.

Indian Journal of Tuberculosis. Indian J Tuberc 2007;54:165-7.

Wares F, Balasubramanian R, Mohan A. Extra Pulmonary Tuberculosis, Management and Control. In: Fraser Wares, R. Balasubramanian, A. Mohan and S.K. Sharma, ed S.P. Agarwal and L. S. Chauhan’s Tuberculosis Control in India; Elsevier. 2005:95-114.

TB India 2007- RNTCP status Report. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Nirman Bhawan, New Delhi, 2007.

Arora VK, Gupta Rajnish. Trends of EPTB under Revised National TB Control Programme: A study from South Delhi. Indian J Tuberc. 2006;53:77-83.

Arora VK, Gupta R. Directly observed treatment for tuberculosis. Indian J Paedtr. Fanning A. Tuberculosis. Extrapulmonary disease. CMAJ. 1999;160:1597-603.

Maher D, Chaulet P, Spinaci S, Harries A. Treatment of tuberculosis: guidelines for national programmes. Geneva: World Health Organization, 1997.

Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004;120:316-53.

Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extra pulmonary tuberculosis. Clin Infect Dis. 2004;38:199-205.

Noertjojo K, Tam CM, Chan SL, Chan-Yeung MM. Extra-pulmonary and pulmonary tuberculosis in Hong Kong. Int J Tuberc Lung Dis. 2002;6:879-86.

Musellim B, Erturan S, Sonmez Duman E, Ongen G. Comparison of extra-pulmonary and pulmonary tuberculosis cases: Factors influencing the site of reactivation. Int J Tuberc Lung Dis. 2005;9:1220-3.

Ilgazli A, Boyaci H, Basyigit I, Yildiz F. Extra pulmonary tuberculosis: Clinical and epidemiologic spectrum of 636 cases. Arch Med Res. 2004;35:435-41.

Rama Prakasha S, Suresh G, Ganesh Kumar S. Mapping the Pattern and Trends of Extrapulmonary Tuberculosis. J Glob Infect Dis. 2013;5(2):54-9.

Özvaran MK, Baran R, Tor M, Dilek I. Extrapulmonary tuberculosis in non-human immunodeficiency virus-infected adults in an endemic region Ann Thorac Med. 2007;2(3):118-21.

Humphries MJ, Lam WK, Teoh R. In: Lymph Node Tuberculosis in Clinical Tuberculosis. Davies PD, editor. London, UK: Chapman and Hall Medical. 1995:94-8.

Van Loenhout-Rooyackers JH, Laheij RJ, Richter C, Verbeek AL. Shortening the duration of treatment for cervical tuberculosis lymphadenitis. Eur Respir J. 2000;15:192.

Shiba N, Preeti NP. Diversities in presentations of extrapulmonary tuberculosis. Science.gov (United States), 2013.

Gonzalez OY, Adams G, Teeter LD, Bui TT, Musser JM, Graviss EA. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis. 2003;7:1178-85.

Ilgazli A, Boyaci H, Basyigit I, Yildiz F. Extrapulmonary tuberculosis: Clinical and epidemiologic spectrum of 636 cases. Arch Med Res. 2004;35:435-41.

Humphries MJ, Lam WK, Teoh R. In: Lymph Node Tuberculosis in Clinical Tuberculosis. Davies PD, editor. London, UK: Chapman and Hall Medical. 1995:94-8.

Maltezou HC, Spyridis P, Kafetzis DA. Extra-pulmonary tuberculosis in children. Arch Dis Child. 2000;83:342-6.

Uygur-Bayramiçli O, Dabak G, Dabak R. A clinical dilemma: Abdominal tuberculosis. World J Gastroenterol. 2003;9:1098-101.

Chennaveerappa PK, Siddharam SM, Halesha BR, Vittal BG, Jayashree N. Treatment outcome of tuberculosis patients registered at dots centre in a teaching hospital, South India. Int J Biol Med Res. 2011;2:487-9.

Downloads

Published

2017-01-16

How to Cite

Mavila, R., Kottarath, M., Nair, S., & Thaha, M. M. (2017). Site predilection of extrapulmonary tuberculosis: study from a tertiary care centre. International Journal of Research in Medical Sciences, 3(11), 3386–3390. https://doi.org/10.18203/2320-6012.ijrms20151197

Issue

Section

Original Research Articles